| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 575.1MM | +0% |
| Gross Profit | 133.5MM | - |
| Cost Of Revenue | 441.6MM | -1% |
| Operating Income | 49.1MM | +19% |
| Operating Expenses | 84.4MM | - |
| Net Income | 1.4MM | +8% |
| G&A | 55.7MM | +2% |
| Amortization | 51.8MM | +3% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Best Healthcare Stocks to Buy Under $20. Global Healthcare Outlook for 2024 As 2024 progresses, the optimism surrounding the healthcare […]
MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the confere
Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprintMURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its 2023 Environmental, Social and Governance (ESG) report. The report details the company’s commitment to improving access to healthcare, bringing
MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the
Voss Capital, LLC an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned 19.4% and 18.6% net of fees and expenses respectively, in the fourth quarter compared to a 14.0% return for the […]
Strong Year-Over-Year Performance Highlighted by Revenue and Adjusted EBITDA Increases
R1 RCM Inc. (NASDAQ:RCM) Q4 2023 Earnings Call Transcript February 27, 2024 R1 RCM Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. My name is Ellie, and I will be your conference operator for today. At this […]
Q4 2023 R1 RCM Inc Earnings Call
While the top- and bottom-line numbers for R1 RCM Inc. (RCM) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
R1 RCM Inc. (RCM) delivered earnings and revenue surprises of -100% and 1.79%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?